Early stage IT and Healthcare Investing

David Mack

David Mack, PMV Pharmaceuticals

davidmack

profile

PMV Pharma
""At PMV Pharmaceuticals, we are targeting the most frequently mutated gene in human cancer (p53) to make an unprecedented impact on cancer patients' lives. InterWest Healthcare Partners’ knowledge and understanding of transformative biology made them our ideal lead investor.""
website
http://www.pmvpharma.com
Leadership
David Mack, Co-Founder, President & CEO
Description

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer and infectious disease. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Facebook Google+ Twitter Email LinkedIn Share